Scavenging for Hydroxybenzoic Acids in Cupriavidus necator: Studying Ligand Sensitivity Using a Biosensor-Based Approach
Biomolecules · 2026
DOI: 10.3390/biom16010157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Ingrida Sabaliauske und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bioprocess Research Centre, Faculty of Chemical Technology, Kaunas University of Technology, Radvilėnų Street 19, LT-50254 Kaunas, Lithuania. Hauptthemen laut MEDLINE: Hydroxybenzoates, Biosensing Techniques, Cupriavidus necator. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lietuvos Mokslo Taryba, Research Council of Lithuania.
Abstract (Originalsprache)
The increasing demand for rapid identification of bacteria capable of degrading environmentally relevant organic compounds highlights the need for scalable and selective analytical tools. Cupriavidus necator catabolizes several hydroxybenzoic acids, including 2-hydroxybenzoate (salicylate, 2-HBA), 4-hydroxybenzoate (4-HBA), and 3-hydroxybenzoate (3-HBA), funneling them into central aromatic catabolism via monooxygenation to 2,5-dihydroxybenzoate (gentisate, 2,5-dHBA) and 3,4-dihydroxybenzoate (protocatechuate, 3,4-dHBA) followed by the oxidative cleavage reaction, enabling complete conversion to tricarboxylic acid (TCA) cycle intermediates. To quantify how readily C. necator is able to activate catabolic genes in response to hydroxybenzoic acid, an extracellular ligand, we applied an approach centered on a transcription-factor (TF)-based biosensor that combines ligand-bound regulator activity with a fluorescent reporter. This approach allowed to evaluate the ligand sensitivity by determining gene activation threshold ACmin and half-maximal effective concentration EC50. Amongst studied hydroxybenzoic acids, 2-HBA and 4-HBA sensors from C. necator showed very low thresholds 4.8 and 2.4 μM and EC50 values of 19.91 and 13.06 μM, indicating high sensitivity to these compounds and implicating a scavenging characteristic of associated catabolism. This study shows that the TF-based-biosensor approach applied for mapping functional sensing ranges of hydroxybenzoates combined with the research and informatics of catabolism can advance our understanding of how gene expression regulation systems have evolved to respond differentially to the availability and concentration of carbon sources. Furthermore, it can inform metabolic engineering strategies in the prevention of premature pathway activation or in predicting competitive substrate hierarchies in complex mixed environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioprocess Research Centre, Faculty of Chemical Technology, Kaunas University of Technology, Radvilėnų Street 19, LT-50254 Kaunas, Lithuania.
- Department of Organic Chemistry, Faculty of Chemical Technology, Kaunas University of Technology, Radvilėnų Street 19, LT-50254 Kaunas, Lithuania.
ORCID-Profile: Ingrida Sabaliauske, Ernesta Augustiniene, Monika Tamasauskaite, Naglis Malys
Förderung
- Lietuvos Mokslo Taryba
- Research Council of Lithuania
Zitieren
APA
Sabaliauske, I., Augustiniene, E., Al Akiki Dit Al Mazraani, R., Tamasauskaite, M., & Malys, N. (2026). Scavenging for Hydroxybenzoic Acids in Cupriavidus necator: Studying Ligand Sensitivity Using a Biosensor-Based Approach. Biomolecules. https://doi.org/10.3390/biom16010157
Vancouver
Sabaliauske I, Augustiniene E, Al Akiki Dit Al Mazraani R, Tamasauskaite M, Malys N. Scavenging for Hydroxybenzoic Acids in Cupriavidus necator: Studying Ligand Sensitivity Using a Biosensor-Based Approach. Biomolecules. 2026. doi:10.3390/biom16010157
BibTeX
@article{Sabaliauske2026,
author = {Sabaliauske, Ingrida and Augustiniene, Ernesta and Al Akiki Dit Al Mazraani, Rizkallah and Tamasauskaite, Monika and Malys, Naglis},
title = {Scavenging for Hydroxybenzoic Acids in Cupriavidus necator: Studying Ligand Sensitivity Using a Biosensor-Based Approach},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16010157}
}
EUVIMED